- Главная
- Аналитика приложений
- Biosimilar
- Biosimilar Vs. DRUGDOCS
Biosimilar против DRUGDOCS Использование & Stats
Biologic drugs offer important treatment options for patients suffering from auto-immune disorders such as rheumatoid arthritis and for common cancers including breast and colon. Biosimilar and interchangeable products, which can loosely be thought of as ‘generic’ biologics, are important for promoting competition and driving down costs. The FDA maintains a list of approved biosimilars in the Purple Book. The Biosimilar iOS app provides a handy reference to the Purple Book as well as important information related to prescribing and dispensing for clinicians and pharmacists navigating this complex area of drug therapeutics.
** Disclaimer ** - non-medical users should ask for a doctor’s advice in addition to using this app and before making any medical decisions.
- Apple App Store
- Платный
- Медицина
Рейтинг магазина
- -
DRUGDOCS® provides health professionals with current, evidence-based information on the drugs they prescribe with direct access to publications.
- Apple App Store
- Бесплатный
- Медицина
Рейтинг магазина
- -
Biosimilar vs. DRUGDOCS ranking comparison
Compare Biosimilar ranking trend in the past 28 days vs. DRUGDOCS
Biosimilar#132
Rank
Рейтинг Biosimilar против DRUGDOCS в сравнении по странам
Сравните динамику рейтинга Biosimilar за последние 28 дней с динамикой рейтинга DRUGDOCS.
Все категории
Нет данных
Медицина
Сравните данные с любым сайтом, воспользовавшись бесплатной пробной версией
Biosimilar VS.
DRUGDOCS
декабрь 19, 2024